![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 07 February 2024
Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1370998
This article is a correction to:
LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research
by Feng Y, Yang J, Duan W, Cai Y, Liu X and Peng Y (2024) Front. Oncol. 13:1336251. doi: 10.3389/fonc.2023.1336251
In the published article, there was an error. “Nanchang” is the wrong spelling. The correct spelling should be “Nanchong.”
This correction has been applied to the Abstract, the Methodology under the External Validation section, and to the first line of Table 1.
Table 1 Clinical information on patients aged ≥50 years with advanced pancreatic ductal adenocarcinoma.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: advanced pancreatic ductal adenocarcinoma, nomogram, AJCC staging, risk stratification, cancer-specific survival
Citation: Feng Y, Yang J, Duan W, Cai Y, Liu X and Peng Y (2024) Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research. Front. Oncol. 14:1370998. doi: 10.3389/fonc.2024.1370998
Received: 15 January 2024; Accepted: 18 January 2024;
Published: 07 February 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Feng, Yang, Duan, Cai, Liu and Peng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yong Peng, MTM1MDgwODE2MTVAMTYzLmNvbQ==
†These authors have contributed equally to this work and share first authorship
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.